Hyperion DeFi, Inc. (HYPD) AI Stock Analysis

Hyperion DeFi, Inc., formerly known as Eyenovia, Inc., is a DeFi company based in Dallas, Texas, that operates through two segments: Ophthalmic Technology and Digital Assets. The company engages in building on Hyperliquid, focusing on maintaining a long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. In its healthcare operations, the company is developing the Optejet User Filled Device, which is designed to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products.

Hyperion DeFi recorded a 4-year revenue CAGR of -20.1% from FY2020 to FY2025. Annual revenue was $2.0M in FY2020, rose to $14.0M in FY2021, and subsequently stood at $3,787 in FY2023, $57,336 in FY2024, and $813,455 in FY2025. Net losses were -$19.8M in FY2020, -$12.8M in FY2021, -$27.3M in FY2023, -$49.8M in FY2024, and -$45.3M in FY2025. For FY2025, gross margin reached 62.7% with an operating margin of -2333.4%. For the trailing twelve months ended June 30, 2026, revenue totaled $1.4M with an operating margin of -757.5%, while quarterly revenue grew 1559.5% year-over-year.

As of June 30, 2026, Hyperion DeFi held $9.6M in cash and short-term investments alongside total debt of $8.9M, resulting in net cash of $725,297. The company reported a current ratio of 2.34, total assets of $113.1M, shareholders' equity of $101.9M, and a debt-to-equity ratio of 0.09. Operating cash flow in FY2025 was -$14.8M, with free cash flow also at -$14.8M. Cash usage in FY2025 included $4 in capital expenditures and $892,167 in dividends paid.

Hyperion DeFi has a market cap of $43.2M and an enterprise value of $60.2M. The stock trades at a price-to-sales multiple of 30.8x, compared to the median of 4.1x for its US-listed Healthcare peers. Its enterprise value to revenue multiple is 43.0x, while EV-to-EBITDA sits at 8.0x compared to the US-listed Healthcare peer median of 12.0x. Over the past year, the stock fell 58.3%, trailing the S&P 500 (SPY) return of 16.8%, and is down 99.3% over five years.

Wall Street analyst coverage includes 2 Strong Buy ratings, 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell recommendations. The mean price target is $9.82, representing a 246.0% difference from the last close of $2.84. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $2.3M and an EPS of $7.00. Hyperion DeFi has beaten EPS estimates in 2 of the trailing 4 quarters, and its next earnings date is November 12, 2026.

This page is an AI-written research summary of Hyperion DeFi, Inc. (HYPD). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: HYPD income statement, HYPD balance sheet, HYPD key metrics, HYPD analyst forecast, HYPD chart. See the HYPD stock overview for the latest quote and news.